Výsledky vyhledávání - "E. C. Inwald"

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Autor: O, Ortmann, J-U, Blohmer, N T, Sibert, S, Brucker, W, Janni, A, Wöckel, A, Scharl, S, Dieng, J, Ferencz, E C, Inwald, S, Wesselmann, C, Kowalski, A, Hartkopf

Publikováno v: Journal of cancer research and clinical oncology.

Neoadjuvant chemotherapy (NACT) is frequently used in patients with early breast cancer. Randomized controlled trials have demonstrated similar survival after NACT or adjuvant chemotherapy (ACT). However, certain subtypes may benefit more when NACT c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a3d40125b98f9eaaa74721a3714979bb
https://pubmed.ncbi.nlm.nih.gov/35380257

Zobrazit plný text záznamu

Does cavity margin shaving reduce residual tumor and re-excision rates? A systematic review

Autor: M, Fernandez-Pacheco, O, Ortmann, A, Ignatov, E C, Inwald

Publikováno v: Archives of gynecology and obstetrics.

Cavity shaving (CS) is a surgical technique used in the treatment of breast cancer (BC). It may reduce margin positivity in histologic assessment and consequently reduces re- excision rates in breast conserving surgery (BCS). The evidence for this as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00a627139b489e78b26729263e4c0dd0
https://pubmed.ncbi.nlm.nih.gov/35593951

Zobrazit plný text záznamu

Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry

Autor: O Ortmann, Florian Zeman, Monika Klinkhammer-Schalke, E. C. Inwald, Michael Koller, M. Gerstenhauer, Ferdinand Hofstädter

Publikováno v: BioMed Research International, Vol 2014 (2014)
BioMed Research International

Even though randomized controlled clinical trials demonstrated improved survival by adjuvant trastuzumab treatment of HER2-positive breast cancer patients, data on its effect in clinical routine are scarce. This study evaluated the use and efficacy o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6987a0cf10e37c3a9622de7c9db7bf80
https://doi.org/10.1155/2014/137304

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání